National Institutes of Health Overview

  • Investor Type
  • Government
  • Status
  • Active
  • Professionals
  • 1
Professionals
  • Investments
  • 1,475
  • Portfolio
  • 947
  • Exits
  • 190
Exits

National Institutes of Health General Information

Description

Founded in 1887, the National Institutes of Health is an investment firm headquartered in Bethesda, Maryland. The firm provides grants and venture capital to firms operating in the pharmaceuticals and biotechnology sectors.

Contact Information

Website
www.nih.gov
Formerly Known As
Laboratory of Hygiene
Year Founded
1887
Investor Status
Actively Seeking New Investments
Primary Investor Type
Government
Other Investor Types
Accelerator/Incubator
Primary Office
  • 9000 Rockville Pike
  • Bethesda, MD 20892
  • United States
+1 (301) 000-0000

National Institutes of Health Investments (1,475)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Enspectra Health 26-May-2021 Grant 000 Diagnostic Equipment Product Development
00000000 000000000 17-May-2021 00000 00000 Drug Discovery Generating Revenue
0000000 0000000000 11-May-2021 00000 00.000 Drug Discovery Clinical Trials - Phase 1
000000000 00000000 04-May-2021 00000 000 Drug Discovery Clinical Trials - General
00000000000000000 22-Apr-2021 00000 0000 Other Devices and Supplies Generating Revenue
000000 00000000000 22-Apr-2021 00000 00.000 Discovery Tools (Healthcare) Generating Revenue
000000 000000000 0 19-Apr-2021 00000 00000 00.000 Diagnostic Equipment Generating Revenue
000000 06-Apr-2021 00000 000 Surgical Devices Generating Revenue
Armonica Technologies 29-Mar-2021 Grant 00000 Biotechnology Product In Beta Test
Cellular Logistics 16-Mar-2021 Grant 00000 Biotechnology Generating Revenue
You’re viewing 10 of 1,475 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

National Institutes of Health Exits (190)

Company Name Exit Date Exit Type Exit Size
ieCrowd 21-May-2021 Out of Business
0000000000 17-May-2021 000000000000000000
0000 000000000000 14-May-2021 000 000.00
000000 00000000000 28-Apr-2021 000000000000000000
00000 0 0000000000 23-Apr-2021 000 00 00000000
00000 00000000000 22-Apr-2021 000 0000
000000000 16-Apr-2021 000 00000
000000 (0000000000 01-Apr-2021 0000000000
Dignify Therapeutics 24-Mar-2021 Buyout/LBO
Mesa Biotech 26-Feb-2021 Merger/Acquisition 00000
You’re viewing 10 of 190 exits. Get the full list »

National Institutes of Health Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

National Institutes of Health Team (12)

Name Title Deals Funds Boards Office
Shabestari Shabestari Partner 0 Bethesda, MD
James Anderson Ph.D Director of the Division & Deputy Director for Program Coordination, Planning and Strategic Initiatives 0 Bethesda, MD
Ahmed Hasan Medical Officer & Program Director, NHLBI 0 Bethesda, MD
Francis Collins Ph.D Chief Director 0 Bethesda, MD
J.P. Kim Program Manager & Extramural Data Sharing Policy Officer 0 Bethesda, MD
You’re viewing 5 of 12 team members. Get the full list »

National Institutes of Health Co-Investors (37)

Name With Exits Lead Partner Series Industry
TEDCO 2 Series chart Industry bar
Citadel (Hedge Fund) 0 Series chart Industry bar
Eli Lilly 0 0 Series chart Industry bar
General Catalyst 0 Series chart Industry bar
Western Technology Investment 0 Series chart Industry bar
You’re viewing 5 of 37 co-investors. Get the full list »